BI-DOSIS-NASENSPRAY

European patent · EP3790614 · In force

Register entry

Publication number
EP3790614
Application number
EP19721637
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 8, 2019
Published
Mar 17, 2021
Granted
Apr 10, 2024
Protection ends at the latest
May 7, 2039
Next annual fee due
May 31, 2027
IPC classes
A61M 15/08 (2006.01)
A61M 11/00 (2006.01)
A61M 15/00 (2006.01)
A61M 5/315 (2006.01)
G09B 23/28 (2006.01)
B65B 3/00 (2006.01)
B65B 7/16 (2006.01)
B65B 7/28 (2006.01)
B65B 31/02 (2006.01)
B65B 31/04 (2006.01)
G09B 23/30 (2006.01)
A61M 5/31 (2006.01)
Priority
CH 5752018 08.05.2018
EP 18209897 03.12.2018
PCT application
PCT/EP2019/061827 08.05.2019
PCT publication
WO2019/215235 14.11.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Feb 19, 2025

    Change

    Published in Swissreg on 19.02.2025

  4. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  5. May 28, 2024

    Inventor

    Inventor
    ZADORY, Matthias Gergely, 6301 Zug, FRÖHLICH, Johannes Malta, Rebwiesstrasse 29c, 8702 Zollikon, BIENDL, Stefan Pascal, Birmannsgasse 2, 4055 Basel → ZADORY, Matthias Gergely, 6301 Zug, BIENDL, Stefan Pascal, 4055 Basel, FRÖHLICH, Johannes Malta, 8702 Zollikon

    Published in Swissreg on 28.05.2024

  6. May 6, 2024

    Agent entered

    Representative
    Vossius & Partner, Patentanwälte Rechtsanwälte mbB, Hirschgässlein 11, 4051 Basel

    Published in Swissreg on 06.05.2024

  7. Apr 10, 2024

    Granted

    Published in Swissreg on 10.04.2024

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.